A multi-strain meningococcal B vaccine finally arrives in New Zealand

+Print Archive
PRACTICE

A multi-strain meningococcal B vaccine finally arrives in New Zealand

Contributing writer

Mary Nowlan and Emma Best

Bexsero vaccine
Bexsero has been on the UK childhood schedule since September 2015

CHILD HEALTH

The availability of a meningococcal B vaccine is good news for New Zealand, as MenB is the most prevalent group and the burden of invasive meningococcal disease is high. The overseas experience is summarised here, as well as the recommendations for its use in New Zealand

Key points -Group B meningococcal (MenB) disease is the most common type of invasive meningococcal disease in New Zealand, with the highest incide